Cargando…

Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid

BACKGROUND: Morcellation may lead to intraperitoneal spread of tumor cells, thus making prognosis of undiagnosed uterine leiomyosarcoma (ULMS) worse. However, preoperative diagnosis of ULMS remains challenging. This study aimed to design a preoperative clinical characteristics scoring system for dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guorui, Yu, Xin, Zhu, Lan, Fan, Qingbo, Shi, Honghui, Lang, Jinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268744/
https://www.ncbi.nlm.nih.gov/pubmed/32493236
http://dx.doi.org/10.1186/s12885-020-07003-z
_version_ 1783541683555663872
author Zhang, Guorui
Yu, Xin
Zhu, Lan
Fan, Qingbo
Shi, Honghui
Lang, Jinghe
author_facet Zhang, Guorui
Yu, Xin
Zhu, Lan
Fan, Qingbo
Shi, Honghui
Lang, Jinghe
author_sort Zhang, Guorui
collection PubMed
description BACKGROUND: Morcellation may lead to intraperitoneal spread of tumor cells, thus making prognosis of undiagnosed uterine leiomyosarcoma (ULMS) worse. However, preoperative diagnosis of ULMS remains challenging. This study aimed to design a preoperative clinical characteristics scoring system for differentiating ULMS from uterine fibroid. METHODS: This study enrolled 45 ULMS patients and 180 uterine fibroid patients in Peking Union Medical College Hospital from January 2013 to December 2018. RESULTS: The incidence of occult ULMS was 0.59% (95% CI, 0.39–0.71%). Age ≥ 40 years old (OR 2.826, 95%CI 1.326–5.461), tumor size ≥7 cm (OR 6.930, 95% CI 2.872–16.724), neutrophil-to-lymphocyte ratio (NLR) ≥ 2.8 (OR 3.032, 95%CI 1.288–7.13), number of platelet ≥298 × 10(9)/L (OR 3.688, 95%CI 1.452–9.266) and lactate dehydrogenase (LDH) ≥ 193 U/L (OR 6.479, 95%CI 2.658–15.792) were independent predictors of ULMS. A preoperative clinical characteristics scoring system was designed based on OR values, with a total score of 7 points. Tumor size ≥7 cm, LDH ≥ 193 U/L were assigned 2 points, while age ≥ 40 years old, NLR ≥ 2.8 and number of platelet ≥298 × 10(9)/L were assigned 1 point. Score ≥ 4 points was a useful predictor in diagnosing ULMS from fibroid (sensitivity 0.800, specificity 0.778). CONCLUSIONS: The incidence of occult ULMS was low. Age ≥ 40 years old, tumor size ≥7 cm, LDH ≥ 193 U/L, NLR ≥ 2.8 and number of platelet ≥298 × 10(9)/L were independent predictors of ULMS. The preoperative clinical characteristics scoring system could be helpful in preoperative diagnosis of occult ULMS.
format Online
Article
Text
id pubmed-7268744
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72687442020-06-08 Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid Zhang, Guorui Yu, Xin Zhu, Lan Fan, Qingbo Shi, Honghui Lang, Jinghe BMC Cancer Research Article BACKGROUND: Morcellation may lead to intraperitoneal spread of tumor cells, thus making prognosis of undiagnosed uterine leiomyosarcoma (ULMS) worse. However, preoperative diagnosis of ULMS remains challenging. This study aimed to design a preoperative clinical characteristics scoring system for differentiating ULMS from uterine fibroid. METHODS: This study enrolled 45 ULMS patients and 180 uterine fibroid patients in Peking Union Medical College Hospital from January 2013 to December 2018. RESULTS: The incidence of occult ULMS was 0.59% (95% CI, 0.39–0.71%). Age ≥ 40 years old (OR 2.826, 95%CI 1.326–5.461), tumor size ≥7 cm (OR 6.930, 95% CI 2.872–16.724), neutrophil-to-lymphocyte ratio (NLR) ≥ 2.8 (OR 3.032, 95%CI 1.288–7.13), number of platelet ≥298 × 10(9)/L (OR 3.688, 95%CI 1.452–9.266) and lactate dehydrogenase (LDH) ≥ 193 U/L (OR 6.479, 95%CI 2.658–15.792) were independent predictors of ULMS. A preoperative clinical characteristics scoring system was designed based on OR values, with a total score of 7 points. Tumor size ≥7 cm, LDH ≥ 193 U/L were assigned 2 points, while age ≥ 40 years old, NLR ≥ 2.8 and number of platelet ≥298 × 10(9)/L were assigned 1 point. Score ≥ 4 points was a useful predictor in diagnosing ULMS from fibroid (sensitivity 0.800, specificity 0.778). CONCLUSIONS: The incidence of occult ULMS was low. Age ≥ 40 years old, tumor size ≥7 cm, LDH ≥ 193 U/L, NLR ≥ 2.8 and number of platelet ≥298 × 10(9)/L were independent predictors of ULMS. The preoperative clinical characteristics scoring system could be helpful in preoperative diagnosis of occult ULMS. BioMed Central 2020-06-03 /pmc/articles/PMC7268744/ /pubmed/32493236 http://dx.doi.org/10.1186/s12885-020-07003-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhang, Guorui
Yu, Xin
Zhu, Lan
Fan, Qingbo
Shi, Honghui
Lang, Jinghe
Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
title Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
title_full Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
title_fullStr Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
title_full_unstemmed Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
title_short Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
title_sort preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268744/
https://www.ncbi.nlm.nih.gov/pubmed/32493236
http://dx.doi.org/10.1186/s12885-020-07003-z
work_keys_str_mv AT zhangguorui preoperativeclinicalcharacteristicsscoringsystemfordifferentiatinguterineleiomyosarcomafromfibroid
AT yuxin preoperativeclinicalcharacteristicsscoringsystemfordifferentiatinguterineleiomyosarcomafromfibroid
AT zhulan preoperativeclinicalcharacteristicsscoringsystemfordifferentiatinguterineleiomyosarcomafromfibroid
AT fanqingbo preoperativeclinicalcharacteristicsscoringsystemfordifferentiatinguterineleiomyosarcomafromfibroid
AT shihonghui preoperativeclinicalcharacteristicsscoringsystemfordifferentiatinguterineleiomyosarcomafromfibroid
AT langjinghe preoperativeclinicalcharacteristicsscoringsystemfordifferentiatinguterineleiomyosarcomafromfibroid